AAV Mediated Gene Therapy Restores Hearing in Patients with DNFB9 Deafness

被引：0
|
作者：
Zhang, Shanzhong [1 ]
Qi, Jieyu [1 ]
Tan, Fangzhi [1 ]
机构：
[1] Suzhou Otovia Therapeut Co Ltd, Shanghai, Peoples R China
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
926
引用
收藏
页码：454 / 454
页数：1
相关论文
共 50 条
  • [41] AAV9-mediated gene therapy in a knock-in mouse model of infantile neuroaxonal dystrophy
    Whaler, S.
    Geard, A. F.
    Poupon-Bejuit, L.
    Massaro, G.
    Hughes, M. P.
    Lalji, K.
    Waddington, S. N.
    Kurian, M. A.
    Rahim, A. A.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A12 - A12
  • [42] AAV9-Mediated Gene Therapy for X-Linked Adrenoleukodystrophy (X-ALD)
    Gong, Yi
    Maguire, Casey
    Mu, Dakai
    Moser, Ann
    Ren, JiaQian
    Eichler, Florian
    ANNALS OF NEUROLOGY, 2014, 76 : S53 - S53
  • [43] Autosomal Recessive Non-Syndromic Deafness: Is AAV Gene Therapy a Real Chance?
    Brotto, Davide
    Greggio, Marco
    De Filippis, Cosimo
    Trevisi, Patrizia
    AUDIOLOGY RESEARCH, 2024, 14 (02) : 239 - 253
  • [44] AAV9-mediated gene transfer of desmin restores cytoskeletal integrity and attenuates development of cardiomyopathy in desmin-deficient mice
    Heckmann, M. B.
    Bauer, R.
    Winter, L.
    Strucksberg, K. H.
    Jungmann, A.
    Schroeder, R.
    Katus, H. A.
    Mueller, O. J.
    EUROPEAN HEART JOURNAL, 2015, 36 : 521 - 522
  • [45] Allele-Specific Deafness Gene Disruption through Discrimination of a Single Base Change by S. aureus Cas9KKH Prevents Progressive Hearing Loss after AAV Mediated Gene Delivery
    Gyorgy, Bence
    Pan, Bifeng
    Nist-Lund, Carl
    Kleinstiver, Benjamin P.
    Zaborowski, Mikolaj
    Joung, J. Keith
    Corey, David P.
    Holt, Jeffrey R.
    MOLECULAR THERAPY, 2018, 26 (05) : 170 - 170
  • [46] AAV9-Based Gene Therapy in Aspartylglucosaminuria Mice
    Chen, Xin
    Rozenberg, Alejandra
    Pollard, Laura
    Cathey, Sara
    Gray, Steven
    MOLECULAR THERAPY, 2017, 25 (05) : 314 - 314
  • [47] AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome
    Suzuki-Hatano, Silveli
    Saha, Madhurima
    Rizzo, Skylar A.
    Witko, Rachael L.
    Gosiker, Bennett J.
    Ramanathan, Manashwi
    Soustek, Meghan S.
    Jones, Michael D.
    Kang, Peter B.
    Byrne, Barry J.
    Cade, W. Todd
    Pacak, Christina A.
    HUMAN GENE THERAPY, 2019, 30 (02) : 139 - 154
  • [48] Emerging Issues in AAV-Mediated In Vivo Gene Therapy
    Colella, Pasqualina
    Ronzitti, Giuseppe
    Mingozzi, Federico
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2018, 8 : 87 - 104
  • [49] AAV-mediated Gene therapy for GBA-PD
    Ayloo, S.
    Ryu, J.
    Chou, S.
    Miller, C.
    Blatnik, L.
    Wischhof, E.
    Bu, J.
    McCarty, W.
    Guo, L.
    Nass, S.
    O'Riordan, C.
    Elmer, B.
    Mueller, C.
    Ramachandran, S.
    MOVEMENT DISORDERS, 2024, 39 : S381 - S381
  • [50] Recombinant AAV-mediated gene therapy for Phenylketonuria.
    Charron, CE
    Reyes, L
    Embury, JE
    Steele, HA
    Ross, K
    Lewin, AS
    Flotte, TR
    Laipis, PJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 201 - 201
12345